If the cutoff value of serum HIF-1α level was > 50 μg/L, the incidence of HIF-1α abnormality was 100% in HCC, 89.2% in liver cirrhosis, 66.7% in chronic hepatitis, and none in acute hepatitis or normal control groups. This evidence concerns the gene HIF1A and hepatocellular carcinoma.